CADTH PostMarket Drug Evaluation Request for Proposals

Governance and Public Policy
Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: inquire with unit

Memorial Deadline: Monday 28th, March 2022

External Deadline: Thursday 31st, March 2022


Description

The new CADTH Post-Market Drug Evaluation (PMDE) Program will be launching a re-imagined evidence generation network in September 2022. The program will bring together an external network of Canada’s expert applied researchers, methodologists, and data analysts to provide evidence to answer questions posed by federal, provincial, and territorial decision-makers about post-market drug safety and effectiveness.

As the network is being developed, the PMDE Program will be recruiting network partners. If you are interested in joining the PMDE network to produce evidence for decision-makers, please download the Request for proposal attached.

Proposal Due Date: 2:00 p.m. EDT on March 31, 2022

Enquiries by Email: contracts@cadth.ca

Downloads

C-220350 RFP PMDE GRANT FINAL


Funding Sources

Canadian Agency for Drugs and Technologies in Health (CADTH)



This opportunity was posted by: RGCS

Last modified: February 28, 2022